Literature DB >> 24565714

IgE and IgG binding patterns and T-cell recognition of Fel d 1 and non-Fel d 1 cat allergens.

Belinda J Hales1, Lee Ying Chai2, Lee Hazell2, Claire E Elliot2, Shane Stone2, Serena E O'Neil2, Wendy-Anne Smith2, Wayne R Thomas2.   

Abstract

BACKGROUND: Cat allergy affects approximately 15% of the population and is a major risk factor for asthma. The relative importance of cat allergens other than Fel d 1 is not known.
OBJECTIVE: To compare IgE and IgG antibody binding and T-cell recognition of the major cat allergen Fel d 1 with other cat proteins with known IgE binding properties.
METHODS: IgE, IgG1, and IgG4 antibody to Fel d 1, 2, 3, 4, 7, 8, and the undesignated IgE binding proteins haptoglobin and S100A12 were measured in the plasma of 96 individuals with cat allergy and 78 individuals without cat allergy. Cytokines were measured from T cells stimulated with the cat allergens.
RESULTS: An allergen other than Fel d 1 had the highest IgE binding specificity for 35% of individuals with cat allergy, and it bound more than 50% of their IgE antibody in 70% of these sera. Fel d 4, 7, and 8 were identified as the main contributors to the non-Fel d 1 IgE binding response and elicited inflammatory Th2 cytokines to a similar degree as Fel d 1. As expected, the average percentage of IgE binding to Fel d 1 for individuals was 55%. IgG4 binding to Fel d 1 was detected in both subjects with allergy (30%) and subjects without allergy (19%). IgG4 binding to the other allergens was less prevalent but was found for both groups. IgG1 antibody was not detected to any of the newly described cat proteins.
CONCLUSION: Fel d 4, 7, and 8 are allergens that should be included in the diagnosis and investigation of cat allergy.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cat allergens; Cytokines; IgE; IgG1; IgG4

Mesh:

Substances:

Year:  2013        PMID: 24565714     DOI: 10.1016/j.jaip.2013.08.008

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  8 in total

1.  Allergen ligands in the initiation of allergic sensitization.

Authors:  Wayne R Thomas
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

Review 2.  IgE in the diagnosis and treatment of allergic disease.

Authors:  Thomas A E Platts-Mills; Alexander J Schuyler; Elizabeth A Erwin; Scott P Commins; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2016-04-27       Impact factor: 10.793

3.  Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.

Authors:  Amedee Renand; Luis D Archila; John McGinty; Erik Wambre; David Robinson; Belinda J Hales; Wayne R Thomas; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2015-09-11       Impact factor: 10.793

4.  Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study.

Authors:  Anna Asarnoj; Carl Hamsten; Konrad Wadén; Christian Lupinek; Niklas Andersson; Inger Kull; Mirela Curin; Josep Anto; Jean Bousquet; Rudolf Valenta; Magnus Wickman; Marianne van Hage
Journal:  J Allergy Clin Immunol       Date:  2015-12-10       Impact factor: 10.793

Review 5.  Immune responses to inhalant Mammalian allergens.

Authors:  François Hentges; Cathy Léonard; Karthik Arumugam; Christiane Hilger
Journal:  Front Immunol       Date:  2014-05-21       Impact factor: 7.561

6.  Broad perspectives of allergen specific immunotherapy.

Authors:  Wayne Robert Thomas
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

7.  Fel d1 Blocking Antibodies: A Novel Method to Reduce IgE-Mediated Allergy to Cats.

Authors:  Ebenezer Satyaraj; Peichuan Sun; Scott Sherrill
Journal:  J Immunol Res       Date:  2021-06-19       Impact factor: 4.818

8.  Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen.

Authors:  Ebenezer Satyaraj; Harold James Wedner; Jean Bousquet
Journal:  Allergy       Date:  2019-10       Impact factor: 13.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.